The IciStem consortium, coordinated by IrsiCaixa, presents the third case of cure of HIV infection in the world. This is a man who was withdrawn from supervised antiretroviral treatment for HIV after undergoing a stem cell transplant to treat myeloid leukaemia. Four years later, the virus has not reappeared. The study is published in the journal Nature Medicine, in an article demonstrating the absence of viral particles and immune response against the virus in the patient's body despite not receiving treatment for 4 years, evidence that allows the scientific team to consider the case of the patient from Dsseldorf as a new case of cure.

The study was carried out by the international consortium IciStem, coordinated by the IrsiCaixa AIDS Research Institute - a centre jointly promoted by the "la Caixa" Foundation and the Catalan Government's Department of Health - and the University Medical Center in Utrecht (The Netherlands). "Together with an excellent team of professionals from all over the world, we have been studying these exceptional cases for nine years in which, thanks to a therapeutic strategy, the virus is completely eliminated from the body. We want to understand each step of the cure process in detail in order to design strategies that can be replicated in the entire population," explains Javier Martnez-Picado, ICREA researcher at IrsiCaixa, co-director of IciStem, and co-author of the article.

The Dsseldorf patient, a story of overcoming the disease

In 2008, a medical team in Dsseldorf (Germany) diagnosed HIV infection in a person who would later be known as the Dsseldorf patient because of his uniqueness. Following the diagnosis, the patient was started on antiretroviral treatment, which brought his infection under control and reduced the amount of virus to undetectable levels in his blood. Four years later, in 2012, he developed leukaemia, a cancer of the immune system cells, and had to undergo a stem cell transplant. In such unique cases, a stem cell donor is sought who has the CCR532 mutation. This genetic alteration means that you do not produce one of the gateways for HIV to enter the cells and therefore makes infection more difficult. "It is very complicated for all these factors to coincide, only 1% of the population has this mutation and, in addition, it is necessary for the donor to be a compatible blood donor to avoid transplant rejection," says Maria Salgado, IGTP researcher at IrsiCaixa and co-author of the study. In the case of the Dsseldorf patient, a woman made it possible to fit all the pieces together.

More than 5 years after the transplant, and having gone through two relapses of leukaemia and several complications, the patient stabilised. From there, the research team agreed to take him off antiretroviral treatment for HIV. Today, the patient from Dsseldorf is 53 years old and in good health. "When he stopped treatment, we followed him for 44 months and did not detect any traces of virus in his blood or tissues," says Salgado. "Nor have we seen any immune response characteristic of a viral flare-up. Their defences are not activated against HIV because they don't have to defend themselves against the virus". All these data allow the scientific team to affirm that the person has been cured of HIV infection.

The HIV cure map of the world

The confirmation of the cure for the Berlin and London patients precedes that of the Dsseldorf patient. Although these are the only three cases where it is possible to speak of a cure, the HIV remission of two other patients, the one in New York and the one at the City of Hope Hospital in Duarte, has already been presented at scientific conferences. "Neither of them have special immune characteristics that allow them to control HIV infection spontaneously, but the virus has been eliminated from the body as a result of medical intervention. This differentiates these cases of eradication from the cases of functional cure in elite or post-treatment controllers achieved so far, where people's own bodies had special factors that allowed them to control the virus," says Salgado. The Dsseldorf patient is thus a third proof of concept that demonstrates the possibility of curing HIV and rekindles hope in the scientific world dedicated to fighting the virus.

However, this strategy is very aggressive and not scalable to the rest of the population. Stem cell transplantation is only applied to people who suffer from a haematological disease and have no therapeutic alternative. In the case of people with HIV, there is an alternative, and that is antiretroviral treatment. "One possible strategy that is already being worked on is to introduce the CCR532 mutation through gene therapy to achieve a cure for HIV without having to undergo a transplant," says Martnez-Picado.

See more here:
Third case in the world of cure of HIV after stem cell transplant - Atalayar